Analysis | Metabolite Name | Measured Value | Units | Recovery | Gender | Treatment |
---|---|---|---|---|---|---|
ESI negative ion mode | Glycoursodeoxycholic acid | 0.0000087244 | ug/100mg sample weight | two week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000014605 | ug/100mg sample weight | na | male | No antibiotics |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000015422 | ug/100mg sample weight | two week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000018548 | ug/100mg sample weight | no recovery | female | IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000021278 | ug/100mg sample weight | no recovery | female | IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000021676 | ug/100mg sample weight | four week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000027456 | ug/100mg sample weight | six week recovery | female | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000029197 | ug/100mg sample weight | six week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000031329 | ug/100mg sample weight | six week recovery | female | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000036664 | ug/100mg sample weight | no recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000037005 | ug/100mg sample weight | no recovery | female | IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000039279 | ug/100mg sample weight | no recovery | male | IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000043468 | ug/100mg sample weight | two week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000045907 | ug/100mg sample weight | one week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000049649 | ug/100mg sample weight | six week recovery | male | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000051632 | ug/100mg sample weight | no recovery | male | Vancomycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000052262 | ug/100mg sample weight | no recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000053531 | ug/100mg sample weight | no recovery | female | Vancomycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000055678 | ug/100mg sample weight | four week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000057644 | ug/100mg sample weight | six week recovery | male | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000057912 | ug/100mg sample weight | no recovery | female | Vancomycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000058776 | ug/100mg sample weight | no recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000079719 | ug/100mg sample weight | no recovery | male | Metronidazole treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000087003 | ug/100mg sample weight | three week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000090939 | ug/100mg sample weight | no recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000092153 | ug/100mg sample weight | three week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.000096147 | ug/100mg sample weight | no recovery | male | IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00010172 | ug/100mg sample weight | five week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00010226 | ug/100mg sample weight | no recovery | male | Metronidazole treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00010249 | ug/100mg sample weight | no recovery | female | Kanamycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00010325 | ug/100mg sample weight | na | male | No antibiotics |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00011303 | ug/100mg sample weight | five week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00011997 | ug/100mg sample weight | no recovery | male | Kanamycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00012709 | ug/100mg sample weight | no recovery | male | IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00014859 | ug/100mg sample weight | three week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00015426 | ug/100mg sample weight | no recovery | male | Vancomycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00016381 | ug/100mg sample weight | na | male | No antibiotics |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00016422 | ug/100mg sample weight | one week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00016429 | ug/100mg sample weight | no recovery | female | Kanamycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.0001685 | ug/100mg sample weight | three week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00017777 | ug/100mg sample weight | no recovery | female | Kanamycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00017886 | ug/100mg sample weight | three week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00018386 | ug/100mg sample weight | six week recovery | male | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.0002037 | ug/100mg sample weight | na | female | No antibiotics |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00020783 | ug/100mg sample weight | no recovery | male | Kanamycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00021257 | ug/100mg sample weight | no recovery | male | Vancomycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.0002283 | ug/100mg sample weight | no recovery | female | Metronidazole treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00023226 | ug/100mg sample weight | na | female | No antibiotics |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00023547 | ug/100mg sample weight | no recovery | male | Kanamycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00023611 | ug/100mg sample weight | no recovery | female | Vancomycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00025351 | ug/100mg sample weight | five week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00028212 | ug/100mg sample weight | one week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00029143 | ug/100mg sample weight | three week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00029529 | ug/100mg sample weight | no recovery | male | Metronidazole treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00030156 | ug/100mg sample weight | no recovery | female | Metronidazole treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00039657 | ug/100mg sample weight | six week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00042875 | ug/100mg sample weight | four week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00043114 | ug/100mg sample weight | six week recovery | male | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00047259 | ug/100mg sample weight | two week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00054798 | ug/100mg sample weight | two week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00057466 | ug/100mg sample weight | no recovery | female | Metronidazole treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00060201 | ug/100mg sample weight | two week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00065362 | ug/100mg sample weight | na | female | No antibiotics |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00069102 | ug/100mg sample weight | no recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00081472 | ug/100mg sample weight | no recovery | male | Vancomycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00091348 | ug/100mg sample weight | three week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00097639 | ug/100mg sample weight | six week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00104784 | ug/100mg sample weight | four week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00120424 | ug/100mg sample weight | one week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00123425 | ug/100mg sample weight | six week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00133133 | ug/100mg sample weight | no recovery | male | Metronidazole treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.0015175 | ug/100mg sample weight | no recovery | male | Vancomycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00160254 | ug/100mg sample weight | no recovery | female | Metronidazole treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00160496 | ug/100mg sample weight | one week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00163709 | ug/100mg sample weight | no recovery | male | IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00179727 | ug/100mg sample weight | no recovery | female | Vancomycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00188358 | ug/100mg sample weight | no recovery | male | Vancomycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00193113 | ug/100mg sample weight | six week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00223914 | ug/100mg sample weight | na | male | No antibiotics |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00255735 | ug/100mg sample weight | six week recovery | female | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00257632 | ug/100mg sample weight | no recovery | female | IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00275103 | ug/100mg sample weight | six week recovery | female | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00281731 | ug/100mg sample weight | no recovery | male | Metronidazole treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00282993 | ug/100mg sample weight | one week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00296203 | ug/100mg sample weight | no recovery | female | IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00371407 | ug/100mg sample weight | no recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00382277 | ug/100mg sample weight | no recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00402932 | ug/100mg sample weight | six week recovery | male | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00426811 | ug/100mg sample weight | no recovery | female | Vancomycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00450543 | ug/100mg sample weight | five week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00459894 | ug/100mg sample weight | no recovery | female | Kanamycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00461766 | ug/100mg sample weight | one week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00469902 | ug/100mg sample weight | four week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00492097 | ug/100mg sample weight | five week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00510169 | ug/100mg sample weight | six week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00547501 | ug/100mg sample weight | no recovery | female | Vancomycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00665725 | ug/100mg sample weight | no recovery | male | Kanamycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.0073853 | ug/100mg sample weight | no recovery | male | IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00755475 | ug/100mg sample weight | two week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00879764 | ug/100mg sample weight | no recovery | male | Metronidazole treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00914639 | ug/100mg sample weight | no recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.0093978 | ug/100mg sample weight | two week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.00996708 | ug/100mg sample weight | five week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.01236087 | ug/100mg sample weight | six week recovery | female | Cefoperazone treated IP clindamycin |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.01315146 | ug/100mg sample weight | two week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.01364354 | ug/100mg sample weight | na | male | No antibiotics |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.01383527 | ug/100mg sample weight | four week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.01675699 | ug/100mg sample weight | four week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.01767529 | ug/100mg sample weight | two week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.02209032 | ug/100mg sample weight | no recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.02275228 | ug/100mg sample weight | six week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.02294787 | ug/100mg sample weight | three week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.02357725 | ug/100mg sample weight | three week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.02475342 | ug/100mg sample weight | na | male | No antibiotics |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.02523376 | ug/100mg sample weight | no recovery | female | Kanamycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.03044844 | ug/100mg sample weight | two week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.03162174 | ug/100mg sample weight | five week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.03168519 | ug/100mg sample weight | na | female | No antibiotics |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.03562869 | ug/100mg sample weight | no recovery | female | Kanamycin treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.03587699 | ug/100mg sample weight | na | female | No antibiotics |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.03940827 | ug/100mg sample weight | no recovery | female | Metronidazole treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.04463659 | ug/100mg sample weight | three week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.05770781 | ug/100mg sample weight | na | female | No antibiotics |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.06349054 | ug/100mg sample weight | two week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.07455119 | ug/100mg sample weight | three week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.08098884 | ug/100mg sample weight | one week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.09706834 | ug/100mg sample weight | one week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.10021789 | ug/100mg sample weight | one week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.10430172 | ug/100mg sample weight | three week recovery | male | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | 0.1455542 | ug/100mg sample weight | one week recovery | female | Cefoperazone treated |
ESI negative ion mode | Glycoursodeoxycholic acid | ug/100mg sample weight | no recovery | male | Cefoperazone treated | |
ESI negative ion mode | Glycoursodeoxycholic acid | ug/100mg sample weight | no recovery | male | IP clindamycin | |
ESI negative ion mode | Glycoursodeoxycholic acid | ug/100mg sample weight | one week recovery | female | Cefoperazone treated | |
ESI negative ion mode | Glycoursodeoxycholic acid | ug/100mg sample weight | six week recovery | female | Cefoperazone treated IP clindamycin | |
ESI negative ion mode | Glycoursodeoxycholic acid | ug/100mg sample weight | six week recovery | male | Cefoperazone treated IP clindamycin |